83
Views
51
CrossRef citations to date
0
Altmetric
Original Research

Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer

, , , &
Pages 4209-4221 | Published online: 07 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yonghua Lin, Baoyan Zhang, Linfeng Su, Jianfeng Wei, Zhichao Chen & Min Wu. (2023) Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-12.
Read now
K.T. Ramya Devi, Dharshene Karthik, TharunSelvam Mahendran, M.K. Jaganathan & Sanjana Prakash Hemdev. (2021) Long noncoding RNAs: role and contribution in pancreatic cancer. Transcription 12:1, pages 12-27.
Read now
Lixia Yan, Ze Zhang, Xingmei Yin & Yongxia Li. (2020) RETRACTED ARTICLE: lncRNA NEAT1 Facilitates Cell Proliferation, Invasion and Migration by Regulating CBX7 and RTCB in Breast Cancer. OncoTargets and Therapy 13, pages 2449-2458.
Read now
Yan Liu, Xinyi Liu, Xiaofeng Zhang, Jinhu Deng, Jian Zhang & Hao Xing. (2020) lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway. Cancer Management and Research 12, pages 2685-2695.
Read now
Chen Fang, Le Xu, Wei He, Jun Dai & Fukang Sun. (2019) Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis. Cell Cycle 18:23, pages 3288-3299.
Read now

Articles from other publishers (45)

Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, Gautam Sethi & Xianbin Zhang. (2023) Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance. Cancer and Metastasis Reviews 43:1, pages 29-53.
Crossref
Haifeng Gao, Wei Chen, Gaojian Pan, Hui Liu, Jinke Qian, Weijun Tang, Wei Wang & Shilei Qian. (2022) A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways. Aging 15:24, pages 15624-15639.
Crossref
Ahmed I. Abulsoud, Shereen Saeid Elshaer, Nourhan M. Abdelmaksoud, Mohamed Bakr Zaki, Hesham A. El-Mahdy, Ahmed Ismail, Tohada M. AL-Noshokaty, Doaa Fathi, Mustafa Ahmed Abdel-Reheim, Osama A. Mohammed & Ahmed S. Doghish. (2023) Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer. Pathology - Research and Practice 251, pages 154855.
Crossref
Rahul Bhattacharjee, Neeraj Prabhakar, Lamha Kumar, Arkadyuti Bhattacharjee, Sulagna Kar, Sumira Malik, Dhruv Kumar, Janne Ruokolainen, Arvind Negi, Niraj Kumar Jha & Kavindra Kumar Kesari. (2023) Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology 46:4, pages 885-908.
Crossref
Xiaopeng Lu & Hongguo Xie. (2022) Circ_0001971 makes progress of oral squamous cell carcinoma by targeting miR‐107/FZD4 axis. Oral Diseases 29:5, pages 1979-1990.
Crossref
Jia Zhou, Guodong Song, Mingqi Su, Hui Zhang, Tingsong Yang & Zhenshun Song. (2023) Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR ‐497‐5p to upregulate expression of CCND1 . Environmental Toxicology 38:6, pages 1251-1264.
Crossref
Tohada M. Al-Noshokaty, Abdallah Mansour, Rehab Abdelhamid, Nourhan Abdellatif, Ayat Alaaeldien, Tasnim Reda, Nourhan M. Abdelmaksoud, Ahmed S. Doghish, Ahmed I. Abulsoud & Shereen Saeid Elshaer. (2023) Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. Pathology - Research and Practice 245, pages 154438.
Crossref
宇欣 桂. (2023) Research Progress of lncRNA DLX6-AS1 in Malignant Tumors. World Journal of Cancer Research 13:02, pages 44-50.
Crossref
Yan Ma, Yang Di, Qiuyue Li, Qilin Zhan, Xiaomeng He, Shanshan Liu, Heng Zou, Christopher Corpe, Litian Chen & Jin Wang. (2022) LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer. Discover Oncology 13:1.
Crossref
Yanyan Zhao & Pei Li. (2022) Strategies of LncRNA DLX6-AS1 on Study and Therapeutics. Frontiers in Genetics 13.
Crossref
Soudeh Ghafouri-Fard, Sajad Najafi, Bashdar Mahmud Hussen, Aryan R. Ganjo, Mohammad Taheri & Mohammad Samadian. (2022) DLX6-AS1: A Long Non-coding RNA With Oncogenic Features. Frontiers in Cell and Developmental Biology 10.
Crossref
Mourad Assidi, Abdelbaset Buhmeida, Maryam H. Al-Zahrani, Jaudah Al-Maghrabi, Mahmood Rasool, Muhammad I. Naseer, Heba Alkhatabi, Abdulmajeed F. Alrefaei, Ali Zari, Razan Elkhatib, Adel Abuzenadah, Peter N. Pushparaj & Muhammad Abu-Elmagd. (2022) The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach. Frontiers in Molecular Biosciences 9.
Crossref
Xi Xu, Yan Zhang, Meizhu Wang, Xiaoxiao Zhang, Wenrui Jiang, Shuo Wu & Xinyu Ti. (2022) A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell. Critical Reviews in Eukaryotic Gene Expression 32:8, pages 43-53.
Crossref
Ning Li, Yuru Wang, Xinyue Wang, Na Sun & Yan-Hua Gong. (2022) Pathway network of pyroptosis and its potential inhibitors in acute kidney injury. Pharmacological Research 175, pages 106033.
Crossref
Yang Li, Zirong Liu & Yamin Zhang. (2021) Expression and prognostic impact of FZDs in pancreatic adenocarcinoma. BMC Gastroenterology 21:1.
Crossref
Guifeng Zhang, Zhenhua Liu, Jiangming Zhong & Li Lin. (2021) Circ‐ACAP2 facilitates the progression of colorectal cancer through mediating miR‐143‐3p/FZD4 axis. European Journal of Clinical Investigation 51:12.
Crossref
Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, Hamid Reza Mirzaei, Maryam Mahjoubin-Tehran, Hashem khanbabaei, Hamed Kowsari, Layla Shojaie, Maryam Ebadi Fard Azar, Michael R. Hamblin & Hamed Mirzaei. (2021) Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Therapy 28:12, pages 1229-1255.
Crossref
Wei-Qi KongJian-Jing LiangJing DuZhen-Xiong YePing GaoYu-Long Liang. (2021) Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis. Cancer Biotherapy and Radiopharmaceuticals 36:9, pages 753-764.
Crossref
Li-Ya Ji, Ming Wei, Yuan-Yuan Liu, Zheng-Li Di & San-Zhong Li. (2021) miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis. Oncology Reports 46:6.
Crossref
Ivana Samaržija. (2021) Wnt Signaling Pathway Is among the Drivers of Liver Metastasis. Livers 1:4, pages 180-200.
Crossref
Alex J. Smith, Kayla M. Sompel, Alamelu Elango & Meredith A. Tennis. (2021) Non-Coding RNA and Frizzled Receptors in Cancer. Frontiers in Molecular Biosciences 8.
Crossref
Leilei Yang, Tienan Bi, Shenkang Zhou, Yuefu Lan & Ruili Zhang. (2021) CircRASSF2 facilitates the proliferation and metastasis of colorectal cancer by mediating the activity of Wnt/β-catenin signaling pathway by regulating the miR-195-5p/FZD4 axis. Anti-Cancer Drugs 32:9, pages 919-929.
Crossref
Yalan Luo, Peng Ge, Mengfei Wang, Haiyang Chen, Jiayue Liu, Tianfu Wei, Yuankuan Jiang, Jialin Qu & Hailong Chen. (2021) Research progress of DLX6-AS1 in human cancers. Human Cell 34:6, pages 1642-1652.
Crossref
S. Sun, J. Wang, J. Liu, F. Yin, C. Xin, X. Zeng, J. Li & Q. Chen. (2021) MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC . Journal of Dental Research 100:7, pages 739-745.
Crossref
Ammad Ahmad Farooqi, Sawera Nayyab, Chiara Martinelli, Rossana Berardi, Hector Katifelis, Maria Gazouli & William C. Cho. (2021) Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer. Frontiers in Oncology 11.
Crossref
Qiuxian Zheng, Xinyu Gu, Qin Yang, Qingfei Chu, Yiyang Dai & Zhi Chen. (2021) DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression. Clinica Chimica Acta 517, pages 1-8.
Crossref
Tingting Jia, Fengze Wang, Bo Qiao, Yipeng Ren, Lejun Xing, Haizhong Zhang & Hongbo Li. (2021) Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma. Frontiers in Molecular Biosciences 8.
Crossref
Dainan Zhang, Shunchang Ma, Chuanbao Zhang, Peiliang Li, Beibei Mao, Xiudong Guan, Wenjianlong Zhou, Jiayi Peng, Xi Wang, Shaomin Li & Wang Jia. (2021) MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis. Frontiers in Oncology 11.
Crossref
Chengyu Hu, Kai Liu, Bei Wang, Wen Xu, Yexiang Lin & Chengfu Yuan. (2021) DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA. Current Pharmaceutical Design 27:9, pages 1211-1218.
Crossref
Yuanfang Zheng, Jiyuan Liu, Ping Chen, Lu Lin, Yinzhu Luo, Xiaoying Ma, Jincai Lin, Ying Shen & Liyan Zhang. (2021) RETRACTED: Exosomal miR-22-3p from human umbilical cord blood-derived mesenchymal stem cells protects against lipopolysaccharid-induced acute lung injury. Life Sciences 269, pages 119004.
Crossref
Amar Balihodzic, Dominik A. Barth, Felix Prinz & Martin Pichler. (2021) Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer. Cancers 13:5, pages 977.
Crossref
Anita Alizadeh, Asiyeh Jebelli, Behzad Baradaran, Mohammad Amini, Fatemeh Oroojalian, Mahmoud Hashemzaei, Ahad Mokhtarzadeh & Michael R Hamblin. (2021) Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers. Gene 769, pages 145224.
Crossref
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal & Gunes Ozhan. (2021) Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Xian-zhen Ding, Shi-qiang Zhang, Xiao-lan Deng & Jin-hu Qiang. (2021) Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer. Technology in Cancer Research & Treatment 20, pages 153303382199006.
Crossref
Mohsen Sheykhhasan, Yaghoub Ahmadyousefi, Reihaneh Seyedebrahimi, Hamid Tanzadehpanah, Hamed Manoochehri, Paola Dama, Nashmin Fayazi Hosseini, Mohammad Akbari & Mohsen Eslami Farsani. (2021) DLX6-AS1: a putative lncRNA candidate in multiple human cancers. Expert Reviews in Molecular Medicine 23.
Crossref
Shuzhong Liu, An Song, Xi Zhou, Zhen Huo, Siyuan Yao, Bo Yang, Yong Liu & Yipeng Wang. (2020) ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone. Journal of Bone Oncology 24, pages 100304.
Crossref
Jixiang Tan, Jing Fan, Jin He, Lin Zhao & Hongjun Tang. (2020) Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury. Journal of Bioenergetics and Biomembranes 52:5, pages 367-376.
Crossref
Shubo Tian, Jinglei Liu, Shuai Kong & Lipan Peng. (2020) LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis. Bioscience Reports 40:8.
Crossref
Changchun Li, Shan Wang & Chao Yang. (2020) RETRACTED: Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p. Life Sciences 252, pages 117657.
Crossref
Wei‑Hua Liu, Han‑Yong Qiao, Jian Xu, Wei‑Qing Wang, Yi‑Lei Wu & Xia Wu. (2020) LINC00473 contributes to the radioresistance of esophageal squamous cell carcinoma by regulating microRNA‑497‑5p and cell division cycle 25A. International Journal of Molecular Medicine 46:2, pages 571-582.
Crossref
Tao Xu, Ting Lei, Si-Qiao Li, Er-Hui Mai, Fei-Hu Ding & Bin Niu. (2020) DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p . World Journal of Gastroenterology 26:15, pages 1745-1757.
Crossref
Sen Hong, Zhenkun Yan, YuMei Song, MiaoMiao Bi & Shiquan Li. (2020) LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer. Aging 12:6, pages 5183-5194.
Crossref
Jinan Guo, Zhixin Chen, Hongtao Jiang, Zhou Yu, Junming Peng, Jing Xie, ZaiShang Li, Weiqing Wu, Zhiqiang Cheng & Kefeng Xiao. (2019) The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway. Cancer Cell International 19:1.
Crossref
Qiaoge Guo, Hui Sun, Kunpeng Zheng, Shaojie Yin & Junjie Niu. (2019) Long non-coding RNA DLX6-AS1/miR-141-3p axis regulates osteosarcoma proliferation, migration and invasion through regulating Rab10. RSC Advances 9:58, pages 33823-33833.
Crossref
Xilin Zhang, Huihui Guo, Ying Bao, Huanming Yu, Dong Xie & Xiang Wang. (2019) Exosomal long non‑coding RNA DLX6‑AS1 as a potential diagnostic biomarker for non‑small cell lung cancer. Oncology Letters.
Crossref